| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/27/2008 | WO2008035209A2 Quinoline and quinazoline derivatives as inhibitors of protein tyrosine kinase activity |
| 03/27/2008 | WO2008035192A2 Method of preparation of amorphous rabeprazole sodium |
| 03/27/2008 | WO2008034891A2 Novel genes related to glutaminyl cyclase |
| 03/27/2008 | WO2008034863A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 03/27/2008 | WO2008034600A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 03/27/2008 | WO2008021928A3 Hepatitis c virus inhibitors |
| 03/27/2008 | WO2008010934A3 Triazolyl phenyl benzenesulfonamides |
| 03/27/2008 | WO2008009405A3 Novel pyridazine derivatives |
| 03/27/2008 | WO2008002674A3 Bicyclic compositions and methods for modulating a kinase cascade |
| 03/27/2008 | WO2008002671A3 Metalloprotease inhibitors |
| 03/27/2008 | WO2007136668A9 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 03/27/2008 | WO2007094513A3 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 03/27/2008 | WO2007084314A3 MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 03/27/2008 | WO2007056163A3 Aminopyrimidines useful as kinase inhibitors |
| 03/27/2008 | WO2007020411A8 Amide derivatives |
| 03/27/2008 | US20080076934 (R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1- (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition |
| 03/27/2008 | US20080076932 A process for the preparation of phenyltetrazole compounds |
| 03/27/2008 | US20080076918 Quinoxaline compounds |
| 03/27/2008 | US20080076816 Non-Covalent Complexes Comprising Carbon Nanotubes |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | US20080076774 Kinase Modulators and Methods of Use |
| 03/27/2008 | US20080076767 Controlling cell proliferation, cell differentiation,autoimmune disease; N-[4-(3-amino-1,2-benzisoxazol-4-yl)phenyl]-N'-(3-methylphenyl)urea; 2-[4-(3-amino-1H-indazol-4-yl)phenyl]-N-(3-chlorophenyl)acetamide; N-[4-(3-amino-1,2-benzisothiazol-4-yl)phenyl]-N'-(3,5-dimethylphenyl)urea; anticarcinogenic |
| 03/27/2008 | US20080075965 Maleimide compositions and methods for use thereof |
| 03/27/2008 | DE102006043443A1 Neue aza-bicyclische Verbindungen und ihre Verwendung New aza-bicyclic compounds and their use |
| 03/27/2008 | CA2664411A1 Platelet adp receptor inhibitors |
| 03/27/2008 | CA2663635A1 Novel genes related to glutaminyl cyclase |
| 03/27/2008 | CA2662838A1 Oxindole derivatives |
| 03/27/2008 | CA2662484A1 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 03/27/2008 | CA2662359A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 03/27/2008 | CA2603705A1 A process for the preparation of phenyltetrazole compounds |
| 03/26/2008 | EP1903040A1 Method for producing 4(3h)-quinazolinone derivative |
| 03/26/2008 | EP1903038A1 N-(1-hetaryl-piperidin-4-yl)-(het)arylamide as EP2 receptor modulators |
| 03/26/2008 | EP1902717A2 Vasopressin antagonist and oxytocin antagonist |
| 03/26/2008 | EP1902052A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 03/26/2008 | EP1902032A1 Pharmaceutical compounds |
| 03/26/2008 | EP1902028A2 Histamine h3 receptor antagonists |
| 03/26/2008 | EP1902027A1 3-spir0cycl0pr0pyl2-0xind0le kinase inhibitors |
| 03/26/2008 | EP1902026A2 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 03/26/2008 | EP1902025A1 Kinase inhibitors |
| 03/26/2008 | EP1902024A2 Kinase inhibitors |
| 03/26/2008 | EP1901608A1 Substituted arylpyrazoles as parasiticidal agents |
| 03/26/2008 | EP1751132B1 2-substituted pyrimidines and their use as pesticides |
| 03/26/2008 | EP1660460B1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
| 03/26/2008 | EP1613619B1 Quinazoline derivatives for treatment of cancer |
| 03/26/2008 | EP1583763B1 Benzoazolylpiperazine derivatives having vr1-antagonist activity |
| 03/26/2008 | EP1562934B1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 03/26/2008 | EP1556362B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
| 03/26/2008 | CN101151261A Pyrimidine compounds having tie2 (TEK) inhibitory activity |
| 03/26/2008 | CN101151259A Heteroaryl urea derivatives useful for inhibiting CHKI |
| 03/26/2008 | CN101151253A Substituted n-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators |
| 03/26/2008 | CN101151252A Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |
| 03/26/2008 | CN100376568C Method for synthesising 5-chloro-1-aryl-4-(4, 5-dicyano-1h-imidazol-2-yl)-3-alkyl-1h-pyrazole derivatives |
| 03/26/2008 | CN100376557C Quinoline derivatives as ligands for the neuropeptide y receptor |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348427 Substituted with an amido heterocylic groups; infection by Gram-positive bacteria. |
| 03/25/2008 | US7348357 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 03/25/2008 | US7348355 Treating obesity with the Microsomal triglyceride transfer protein inhibitor (S) N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and another lipid lowering agent such as a statin or fibrate |
| 03/25/2008 | US7348346 Use as antidiabetic agents, treating hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis; (3S, 5S)-4-([5-(Thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-sulfamoyl)-benzoic acid for example |
| 03/25/2008 | US7348335 Compositions useful as inhibitors of JAK and other protein kinases |
| 03/25/2008 | US7348333 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348325 Pyrrolotriazine kinase inhibitors |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/25/2008 | CA2268394C New heterocyclylmethyl-substituted pyrazol derivates |
| 03/25/2008 | CA2173493C Fused pyridazine compounds |
| 03/20/2008 | WO2008033834A1 Pyrimidines derivatives and their use as kinase inhibitors |
| 03/20/2008 | WO2008033764A2 Quinazolinone and isoquinolinone acetamide derivatives |
| 03/20/2008 | WO2008033744A2 Dna methyl transferase inhibitors containing a zinc binding moiety |
| 03/20/2008 | WO2008033562A2 Kinase inhibitor compounds |
| 03/20/2008 | WO2008033278A1 Heterosubstituted n-thiolated beta-lactam compounds and methods of use |
| 03/20/2008 | WO2008032086A1 2-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032077A1 Pyrimidine derivatives |
| 03/20/2008 | WO2008032064A1 Pyrimidine derivatives |
| 03/20/2008 | WO2008032060A1 4-benzimidaz0lyl-6-m0rph0lin0-2-piperazinylpyrimidine derivatives as p13k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032033A1 4-benzimidazolyl-2-morpholino-6-piperazinylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032027A1 Pyrimidine derivatives |
| 03/20/2008 | WO2008031743A1 Heterocyclic bridged biphenyls and their use in oleds |
| 03/20/2008 | WO2008031513A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivates as stimulators of guanylate cyclase for cardiovascular disorders |
| 03/20/2008 | WO2008019276A3 Solid forms of (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of their use |
| 03/20/2008 | WO2008015189A3 Fungicidal n-cycloalkyl-carboxamide derivatives |
| 03/20/2008 | WO2007144512A3 Diazeniumdiolate derivatives, method for the preparation thereof, pharmaceutical compositions thereof, and use of same in the fields of hypertension and cardiovascular pathologies |
| 03/20/2008 | WO2007140174A3 Compounds and methods for modulating fxr |
| 03/20/2008 | WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 03/20/2008 | WO2006094187A3 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/20/2008 | US20080071093 Forming, purification of dipyrromethane and porphrin ; condensation, oxidation, cyclization |
| 03/20/2008 | US20080071085 Chemical process |
| 03/20/2008 | US20080071083 Methods for minimizing thioamide impurities |
| 03/20/2008 | US20080070942 Antiulcer, weakly inhibit gastric acid secretion, reduce the risk of stomach cancer, bioavailability, good pharmacokinetic properties; 2-(pyridylmethylsulfinyl)benzimidazoles such as 2-([4-3-methoxy-propoxy)-3-methylpyridine-2-yl]-methyl-sulfinyl)-1H-5-difluoromethoxybenzimidazole sodium salt |
| 03/20/2008 | US20080070935 Isoquinoline, Quinazoline and Phthalazine Derivatives |
| 03/20/2008 | US20080070930 2-(4-oxo-4,5,6,7-tetrahydroindol-1-yl) or 2-(4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl) pyrimidines or pyrazines; cancer, inflammation, arthritis, angiogenesis, fungal, viral and Plasmodium infections; Heat Shock Protein 90 inhibitors |
| 03/20/2008 | US20080070928 Novel 2-Heteroaryl-Substituted Benzimidazole Derivative |
| 03/20/2008 | US20080070921 Melanocortin receptor modulators; sexual disorders, obesity, cachexia, eating disorders; for example 1,4-bis(2-amino-3-p-tolyl-propionyl)-2-isobutyl-5-(4-(2-aminoethylamino)butyl)piperazine |
| 03/20/2008 | US20080070920 Novel HIV reverse transcriptase inhibitors |
| 03/20/2008 | US20080070915 Poly(ADP-ribose)polymerase (PARP); ischemia, reperfusion injuries, neurological disorders, neuroprotectants, sensitizer for chemotherapy or radiotherapy, anticancer |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/20/2008 | US20080070902 Cinnamide Compound |
| 03/20/2008 | US20080070896 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 03/20/2008 | US20080070093 aromatic resins having heat and oxidation resistance, high doping ability and high conductivity values, used as electrolytes in high temperature proton exchange-membrane fuel cells |